United States Antimony (UAMY) 10-Q 16 Aug 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 16, 2022
Cover [Abstract]
Entity Registrant Name	UNITED STATES ANTIMONY CORPORATION
Entity Central Index Key	0000101538
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Entity Common Stock Shares Outstanding		106,240,361
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-08675
Entity Incorporation State Country Code	MT
Entity Tax Identification Number	81-0305822
Entity Interactive Data Current	Yes
Entity Address Address Line 1	P.O. Box 643
Entity Address City Or Town	Thompson Falls
Entity Address State Or Province	MT
Entity Address Postal Zip Code	59873
City Area Code	406
Local Phone Number	827-3523
Security 12b Title	Common Stock, $0.01 par value
Trading Symbol	UAMY
Security Exchange Name	NYSE

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 8,312,469	$ 21,363,048
Certificates of deposit	259,210	259,210
Accounts receivable	1,604,660	891,314
Prepaid expenses	60,916	0
Inventories (NOTE 5)	590,204	1,055,420
Investments (NOTE 11)	13,299,393	0
Total current assets	24,126,852	23,568,992
Properties, plants and equipment, net (NOTE 6)	11,242,721	11,133,733
Restricted cash for reclamation bonds	57,281	57,281
IVA receivable and other assets	329,163	242,721
Total assets	35,756,017	35,002,727
CURRENT LIABILITIES:
Accounts payable	679,597	1,385,752
Payable to related parties	4,084	0
Accrued liabilities	685,918	621,873
Long-term debt, current portion (NOTE 8)	91,347	13,230
Total current liabilities	1,460,946	2,020,855
Long-term debt, net of current portion (NOTE 8)	265,636	201,920
Stock payable to directors for services	187,500	112,500
Asset retirement obligations and accrued reclamation costs (NOTE 7)	325,657	298,649
Total liabilities	2,239,739	2,633,924
STOCKHOLDERS' EQUITY
Common stock, $.001 par value; 300,000,000 shares authorized; 106,240,361 shares issued and outstanding	1,062,402	1,062,402
Additional paid-in capital	63,991,459	63,991,459
Accumulated deficit	(31,563,788)	(32,711,263)
Total stockholders' equity	33,516,278	32,368,803
Total liabilities and stockholders' equity	35,756,017	35,002,727
Series A Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A: 0 shares issued and outstanding	0	0
Series B Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A: 0 shares issued and outstanding	7,500	7,500
Series C Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A: 0 shares issued and outstanding	1,779	1,779
Series D Preferred Stock Member
STOCKHOLDERS' EQUITY
Series A: 0 shares issued and outstanding	$ 16,926	$ 16,926

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized shares	300,000,000	300,000,000
Common stock, issued shares	106,240,361	106,240,361
Common stock, outstanding shares	106,240,361	106,240,361
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Series A Preferred Stock [Member]
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Series B Preferred Stock [Member]
Preferred stock, issued shares	750,000	750,000
Preferred stock, outstanding shares	750,000	750,000
Preferred stock liquidation preference	$ 956,250	$ 952,500
Series C Preferred Stock [Member]
Preferred stock, issued shares	177,904	177,904
Preferred stock, outstanding shares	177,904	177,904
Preferred stock liquidation preference	$ 97,847	$ 97,847
Series D Preferred Stock Member
Preferred stock, issued shares	1,692,672	1,692,672
Preferred stock, outstanding shares	1,692,672	1,692,672
Preferred stock liquidation preference	$ 4,979,632	$ 4,979,632

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
REVENUE	$ 3,587,925	$ 2,275,562	$ 7,168,231	$ 3,528,849
COST OF REVENUE	2,865,515	2,079,164	5,306,433	3,120,294
GROSS PROFIT	722,410	196,398	1,861,798	408,555
OPERATING EXPENSES
General and administrative	220,591	290,111	381,272	460,161
Salaries and benefits	72,912	77,278	146,047	153,937
Other operating expenses	14,045	0	17,960	184,037
Legal and professional fees	47,927	61,199	170,004	184,336
TOTAL OPERATING EXPENSES	355,475	428,588	715,283	982,471
INCOME (LOSS) FROM OPERATIONS	366,935	(232,190)	1,146,515	(573,916)
OTHER INCOME (EXPENSE)
Interest expense	(3,081)	(880)	(6,063)	(3,135)
Interest and investment income	30,052	13,389	39,706	21,882
Change in fair value of investments	(93,458)	0	(93,458)	0
Trademark and licensing income	60,775	0	60,775	0
Gain on forgiveness - CARES Act debt	0	443,400	0	443,400
Gain on settlement of Hillgrove advance	0	113,422	0	113,422
TOTAL OTHER INCOME (EXPENSE)	(5,712)	569,331	960	575,569
NET INCOME	361,223	337,141	1,147,475	1,653
Preferred dividends	(11,819)	(12,162)	(23,639)	(24,325)
Net income available to common stockholders	$ 349,404	$ 324,979	$ 1,123,836	$ (22,672)
Net income per share of common stock
Basic and diluted			$ 0.01
Weighted average shares outstanding:
Basic	106,240,361	106,315,419	106,240,361	99,513,378
Diluted	106,240,361	108,696,704	106,240,361	99,513,378

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2020		2,678,909	75,949,757
Balance, amount at Dec. 31, 2020	$ 7,186,389	$ 26,788	$ 759,496	$ 39,050,899	$ (32,650,794)
Common shares issued for cash, shares			26,290,000
Common shares issued for cash, amount	24,997,000	0	$ 262,900	24,734,100	0
Common stock issuance costs	(1,654,820)	0	$ 0	(1,654,820)	0
Common stock issued for exercise of warrants, shares			3,723,810
Common stock issued for exercise of warrants, amount	1,763,619	0	$ 37,238	1,726,381	0
Net income (loss)	(335,488)	$ 0	$ 0	0	(335,488)
Balance, shares at Mar. 31, 2021		2,678,909	105,963,567
Balance, amount at Mar. 31, 2021	31,956,700	$ 26,788	$ 1,059,634	63,856,560	(32,986,282)
Balance, shares at Dec. 31, 2020		2,678,909	75,949,757
Balance, amount at Dec. 31, 2020	7,186,389	$ 26,788	$ 759,496	39,050,899	(32,650,794)
Net income (loss)	1,653
Balance, shares at Jun. 30, 2021		2,678,909	106,005,234
Balance, amount at Jun. 30, 2021	32,320,925	$ 26,788	$ 1,060,051	63,883,227	(32,649,141)
Balance, shares at Mar. 31, 2021		2,678,909	105,963,567
Balance, amount at Mar. 31, 2021	31,956,700	$ 26,788	$ 1,059,634	63,856,560	(32,986,282)
Common stock issued for exercise of warrants, shares			41,667
Common stock issued for exercise of warrants, amount	27,084	0	$ 417	26,667	0
Net income (loss)	337,141	$ 0	$ 0	0	337,141
Balance, shares at Jun. 30, 2021		2,678,909	106,005,234
Balance, amount at Jun. 30, 2021	32,320,925	$ 26,788	$ 1,060,051	63,883,227	(32,649,141)
Balance, shares at Dec. 31, 2021		2,620,576	106,240,361
Balance, amount at Dec. 31, 2021	32,368,803	$ 26,205	$ 1,062,402	63,991,459	(32,711,263)
Net income (loss)	786,252	$ 0	$ 0	0	786,252
Balance, shares at Mar. 31, 2022		2,620,576	106,240,361
Balance, amount at Mar. 31, 2022	33,155,055	$ 26,205	$ 1,062,402	63,991,459	(31,925,011)
Balance, shares at Dec. 31, 2021		2,620,576	106,240,361
Balance, amount at Dec. 31, 2021	32,368,803	$ 26,205	$ 1,062,402	63,991,459	(32,711,263)
Net income (loss)	1,147,475
Balance, shares at Jun. 30, 2022		2,620,576	106,240,361
Balance, amount at Jun. 30, 2022	33,516,278	$ 26,205	$ 1,062,402	63,991,459	(31,563,788)
Balance, shares at Mar. 31, 2022		2,620,576	106,240,361
Balance, amount at Mar. 31, 2022	33,155,055	$ 26,205	$ 1,062,402	63,991,459	(31,925,011)
Net income (loss)	361,223	$ 0	$ 0	0	361,223
Balance, shares at Jun. 30, 2022		2,620,576	106,240,361
Balance, amount at Jun. 30, 2022	$ 33,516,278	$ 26,205	$ 1,062,402	$ 63,991,459	$ (31,563,788)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 1,147,475	$ 1,653
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	451,207	442,408
Accretion of asset retirement obligation	11,412	1,732
Common stock payable for directors fees	75,000	56,250
Gain on settlement of Hillgrove advance	0	(113,422)
Gain on forgiveness of Cares Act debt	0	(443,400)
Write down of inventory to net realizable value	136,836	66,054
Change in fair value of investments	93,458	0
Changes in operating assets and liabilities:
Accounts receivable	(713,346)	(362,681)
Inventories	328,380	17,448
Prepaid expenses	(60,916)	0
IVA receivable and other assets	(86,442)	(15,402)
Accounts payable	(706,155)	(519,570)
Accrued liabilities	64,045	(92,927)
Export tax assessment payable	0	(1,120,730)
Payable to related parties	4,084	(154,022)
Net cash provided (used) by operating activities	745,038	(2,236,609)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from redemption of certificates of deposit	0	210,184
Purchase of investments	(13,789,772)	0
Proceeds from sales of investments	396,921	0
Purchase of properties, plants and equipment	(382,999)	(115,127)
Net cash provided (used) by investing activities	(13,775,850)	95,057
CASH FLOWS FROM FINANCING ACTIVITIES:
Change in checks issued and payable	0	(86,685)
Payments on advances from related party	0	(56,416)
Proceeds from issuance of common stock, net of issuance costs	0	23,342,180
Proceeds from exercise of warrants	0	1,790,703
Payments on Hillgrove advances payable	0	(1,020,799)
Principal paid on notes payable to bank	0	(100,000)
Principal payments of long-term debt	(19,767)	(27,926)
Net cash provided (used) by financing activities	(19,767)	23,841,057
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(13,050,579)	21,699,505
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD	21,420,329	722,377
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	8,369,750	22,421,882
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Equipment purchased with note payable	161,600	0
Common stock payable to directors	0	130,483
Payable to related party satisfied with exercise of stock purchase warrants	$ 0	$ 62,500

NATURE OF OPERATIONS

NATURE OF OPERATIONS	6 Months Ended
	Jun. 30, 2022
NATURE OF OPERATIONS
1. NATURE OF OPERATIONS	NOTE 1 - NATURE OF OPERATIONS AGAU Mines, Inc., predecessor of United States Antimony Corporation (“USAC” or “the Company”), was incorporated in June 1968 as a Delaware corporation to mine gold and silver. USAC was incorporated in Montana in January 1970 to mine and produce antimony products. In June 1973, AGAU Mines, Inc. was merged into USAC. In December 1983, the Company suspended its antimony mining operations when it became possible to purchase antimony raw materials more economically from foreign sources. The principal business of the Company has been the production and sale of antimony products. During 2000, the Company formed a 75% owned subsidiary, Bear River Zeolite Company (“BRZ”), to mine and market zeolite and zeolite products from a mineral deposit in southeastern Idaho. In 2001, an operating plant was constructed at the zeolite site and zeolite production and sales commenced. During 2002, the Company acquired the remaining 25% of BRZ and continued to produce and sell zeolite products. During 2005, the Company formed a 100% owned subsidiary, Antimonio de Mexico S.A. de C.V. (“AM”), to explore and develop potential antimony properties in Mexico. During 2006, the Company acquired 100% ownership in United States Antimony, Mexico S.A. de C.V. (“USAMSA”), which became a wholly-owned subsidiary of the Company. In 2018, the Company acquired 100% ownership in Stibnite Holding Company US Inc. (previously Lanxess Holding Company US Inc.), Antimony Mining and Milling US LLC (previously Lanxess Laurel US LLC), a Delaware limited liability company and Lanxess Laurel de Mexico, S.A. de C.V (“Lanxess Laurel Mexico”), a Mexico corporation, both of which became a wholly-owned subsidiary of the Company. In its operations in Montana, the Company produces antimony oxide, antimony metal, and precious metals. Antimony oxide is a fine, white powder that is used primarily in conjunction with a halogen to form a synergistic flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper. Antimony oxide is also used as a color fastener in paint, as a catalyst for production of polyester resins for fibers and film, as a catalyst for production of polyethylene pthalate in plastic bottles, as a phosphorescent agent in fluorescent light bulbs, and as an opacifier for porcelains. The Company also sells antimony metal for use in bearings, storage batteries and ordnance. In its operations in Idaho, the Company produces zeolite, a group of industrial minerals used in a variety of purposes including soil amendment and fertilizer. Zeolite is also used for water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation and other miscellaneous applications.

BASIS OF PRESENTATION AND SIGNI

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2022
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2022, and its results of operations for the three and six months ended June 30, 2022, and 2021, and cash flows for the six months ended June 30, 2022 and 2021. The condensed consolidated balance sheet at December 31, 2021, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. Operating results for the three and six month periods ended June 30, 2022, are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. These unaudited interim financial statements have been prepared by management in accordance with generally accepted accounting principles used in the United States of America (“U.S. GAAP”). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission on March 31, 2022. This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements. Reclassifications Certain reclassifications have been made to conform prior periods’ amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. COVID -19 The Company’s operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and elsewhere, causing disruptions to the Company’s business operations and management. These disruptions are most evident in the Company’s ability to retain and house employees and properly manage them while maintaining proper social distancing and with delays in obtaining materials and supplies. The effects of the continued outbreak of COVID-19 and related government responses could also include extended disruptions to supply chains and capital markets, reduced availability of contractors and a prolonged reduction in economic activity. These effects could have a variety of adverse impacts on the Company, including its ability to conduct operations. The Company has taken steps to mitigate the potential risks to suppliers and employees posed by the spread of COVID-19, including work from home policies where appropriate. The Company will continue to monitor developments affecting both its workforce and contractors, and will take additional precautions as necessary. The ultimate impact of COVID-19 depends on factors beyond management’s knowledge or control, including its duration and third-party actions to contain its spread and mitigate its public health effects. Therefore, the Company cannot estimate the potential future impact to its financial position, results of operations and cash flows, but the impacts could be material. Investments The Company determines the appropriate classification of investments at the time of acquisition and re-evaluates such determinations at each reporting date. Equity securities that have a readily determinable fair value are carried at fair value determined using Level 1 fair value measurement inputs with the change in fair value recognized as unrealized gain (loss) in the consolidated statement of operations each reporting period. Gains and losses on the sale of securities are recognized on a specific identification basis. New Accounting Pronouncements Accounting standards that have been issued or proposed by the Financial Accounting Standards Board (“FASB”) that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

EARNINGS PER SHARE

EARNINGS PER SHARE	6 Months Ended
	Jun. 30, 2022
Net income per share of common stock
3. EARNINGS PER SHARE	NOTE 3– EARNINGS PER SHARE Basic Earnings Per Share (“EPS”) is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur from common shares issuable through stock options and warrants. At June 30, 2022 and 2021, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive are as follows: June 30, 2022 June 30, 2021 Warrants 12,489,922 2,471,089 Convertible preferred stock 1,692,672 1,751,005 TOTAL POSSIBLE DILUTIVE SHARES 14,182,594 4,222,094

REVENUE RECOGNITION

REVENUE RECOGNITION	6 Months Ended
	Jun. 30, 2022
REVENUE RECOGNITION
4. REVENUE RECOGNITION	NOTE 4 – REVENUE RECOGNITION Products consist of the following: · Antimony: includes antimony oxide, sodium antimonate, antimony trisulfide and antimony metal · Zeolite: includes coarse and fine zeolite crushed in various sizes · Precious metals: includes unrefined and refined gold and silver Sales of products for the three-months ended June 30, 2022 and 2021 were as follows: For the three months ended June 30, 2022 June 30, 2021 Antimony $ 2,472,081 $ 1,428,939 Zeolite 1,020,391 716,428 Precious metals 95,453 130,195 TOTAL REVENUE BY PRODUCT $ 3,587,925 $ 2,275,562 Sales of products for the six months ended June 30, 2022 and 2021 were as follows: For the six months ended June 30, 2022 June 30, 2021 Antimony $ 5,301,011 $ 2,086,046 Zeolite 1,694,433 1,236,375 Precious metals 172,787 206,428 TOTAL REVENUE BY PRODUCT $ 7,168,231 $ 3,528,849 For the three and six months ended June 30, 2022, the Company also received royalties related to a trademark and licensing agreement in its antimony business segment. For the three and six months ended June 30, 2022, trademark and licensing income of $60,775 is included in other income in the antimony business segment (Note 12). For the three and six months ended June 30, 2021, trademark and licensing income was $Nil. The Company’s trade accounts receivable balance related to contracts with customers was $1,604,660 at June 30, 2022 and $891,314 at December 31, 2021. The Company’s products do not involve any warranty agreements and product returns are not typical.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2022
INVENTORIES
5. INVENTORIES	NOTE 5– INVENTORIES Inventories at June 30, 2022 and December 31, 2021 consisted primarily of finished antimony products, antimony metal, antimony ore, and finished zeolite products that are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products, antimony metal and finished zeolite products costs include raw materials, direct labor and processing facility overhead costs and freight. Inventories at June 30, 2022 and December 31, 2021 are as follows: June 30, 2022 December 31, 2021 Antimony Metal $ 128,591 $ 234,461 Antimony Oxide 278,134 439,086 Antimony Ore Concentrates 28,392 119,046 Total antimony 435,117 792,593 Zeolite 155,087 262,827 TOTAL INVENTORIES $ 590,204 $ 1,055,420 Inventories are valued at cost except for the portion related to Mexican operations which are valued at net realizable value because the production costs of the Mexican inventory were greater than the amount the Company expected to receive on the sale of the pounds of antimony contained in inventory. The adjustment to inventory, which is included in cost of revenue on the statements of operations was $136,836 and $66,054 for the six months ended June 30, 2022 and 2021, respectively. Antimony oxide and metal inventory consisted of finished product held at the Company’s plants in Montana and Mexico. Antimony concentrates and ore were held primarily at sites in Mexico. The Company’s zeolite inventory consists of saleable zeolite material.

PROPERTIES PLANTS AND EQUIPMENT

PROPERTIES PLANTS AND EQUIPMENT	6 Months Ended
	Jun. 30, 2022
PROPERTIES PLANTS AND EQUIPMENT
6. PROPERTIES, PLANTS AND EQUIPMENT	NOTE 6 – PROPERTIES, PLANTS AND EQUIPMENT The major components of the Company’s properties, plants and equipment by segment at June 30, 2022 and December 31, 2021 are shown below: Antimony Segment Zeolite Segment Precious Metals June 30, 2022 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,759,271 $ 9,197,870 $ 4,051,016 $ 1,347,912 $ 16,356,069 Buildings 243,248 590,128 801,764 - 1,635,140 Construction in progress - 280,406 332,629 - 613,035 Land and other 2,431,387 2,656,037 16,753 - 5,104,177 4,433,906 12,724,441 5,202,162 1,347,912 23,708,421 Accumulated depreciation (2,747,396 ) (5,904,748 ) (3,318,286 ) (495,270 ) (12,465,700 ) $ 1,686,510 $ 6,819,693 $ 1,883,876 $ 852,642 $ 11,242,721 Antimony Segment Zeolite Segment Precious Metals December 31, 2021 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,684,977 $ 8,905,899 $ 3,853,056 $ 1,330,394 $ 15,774,326 Buildings 243,248 870,534 801,764 - 1,915,546 Construction in progress - 280,406 184,972 - 465,378 Land and other 2,431,387 2,640,441 16,753 - 5,088,581 $ 4,359,612 $ 12,697,280 $ 4,856,545 $ 1,330,394 $ 23,243,831 Accumulated depreciation (2,732,809 ) (5,622,555 ) (3,314,658 ) (440,076 ) (12,110,098 ) $ 1,626,803 $ 7,074,725 $ 1,541,887 $ 890,318 $ 11,133,733 At June 30, 2022 and December 31, 2021, the Company had $613,035 and $665,175, respectively, of assets that were not yet placed in service and have not yet been depreciated.

ASSET RETIREMENT OBLIGATION AND

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS	6 Months Ended
	Jun. 30, 2022
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS
7. ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS	NOTE 7 – ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS Changes in the asset retirement obligation for the three and six months ended June 30, 2022 and 2021 are as follows: Three months ended June 30, 2022 2021 Asset retirement obligation, beginning of period $ 192,881 $ 184,219 Change in estimate of asset retirement obligation 15,596 - Accretion expense 9,680 1,732 Asset retirement obligation, end of period $ 218,157 $ 185,951 Six months ended June 30, 2022 2021 Asset retirement obligation, beginning of period $ 191,149 $ 184,219 Change in estimate of asset retirement obligation 15,596 - Accretion expense 11,412 1,732 Asset retirement obligation, end of period $ 218,157 $ 185,951 The Company’s total asset retirement obligation and accrued reclamation costs of $325,657 and $298,649, at June 30, 2022 and December 31, 2021, respectively, includes reclamation obligations for the Idaho and Montana operations of $107,500.

DEBT

DEBT	6 Months Ended
	Jun. 30, 2022
DEBT
8. DEBT	NOTE 8 – DEBT Long term debt at June 30, 2022 and December 31, 2021 is as follows: June 30, 2022 December 31, 2021 Promissory note payable to First Security Bank of Missoula, bearing interest at 2.25%, payable in 59 monthly installments of $1,409 with a final payment of $152,726 maturing November 9, 2026; collateralized by a lien on Certificate of Deposit $ 208,046 $ 215,150 Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck 148,937 - 356,983 215,150 Less current portion (91,347 ) (13,230 ) Long term portion $ 265,636 $ 201,920 At June 30, 2022, principal payments on debt are due as follows: Twelve months ending June 30, Principal payment 2023 $ 91,347 2024 82,573 2025 12,925 2026 13,219 2027 156,919 $ 356,983

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2022
COMMITMENTS AND CONTINGENCIES
9. COMMITMENTS AND CONTINGENCIES	NOTE 9 – COMMITMENTS AND CONTINGENCIES The Company follows U.S. GAAP guidance in determining its accrual and disclosures with respect to loss contingencies, and evaluate such accruals and contingencies for each reporting period. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information available prior to issuance of the financial statements indicates that it is probable that a liability could be incurred and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred. From time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. At June 30, 2022 and December 31, 2021, the Company had accrued liabilities of $1,270 and $Nil, respectively, relating to such assessments. The Company pays various royalties on the sale of zeolite products. On a combined basis, royalties vary from 8%-13%. During the three months ended June 30, 2022 and 2021, the Company incurred royalty expense of $85,870 and $69,437, respectively. During the six months ended June 30, 2022 and 2021, the Company incurred royalty expense of $147,900 and $131,567 respectively. Royalty expense is included in cost of goods sold on the condensed consolidated statement of operations. At June 30, 2022 and December 31, 2021, the Company had accrued royalties payable of $409,887 and $346,242 respectively, which is included in accrued liabilities on the condensed consolidated balance sheets. The Company is currently in negotiations with certain royalty holders to modify the terms of the agreements.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	6 Months Ended
	Jun. 30, 2022
STOCKHOLDERS' EQUITY
10. STOCKHOLDERS' EQUITY	NOTE 10 – STOCKHOLDERS’ EQUITY During the six months ended June 30, 2021, the Company sold shares of its common stock in two separate transactions: on February 3, 2021, 15,300,000 shares were sold at $0.70 for gross proceeds of $10,710,000; and on February 18, 2021, 10,990,000 shares were sold at $1.30 for gross proceeds of $14,287,000. A total of $1,654,820 of issuance costs were incurred on these sales. During the six months ended June 30, 2021, the Company issued 3,765,477 shares of common stock and received $1,790,703 in cash from the exercise of warrants. During the three months ended June 30, 2022 and June 30, 2021, the Company expensed $46,875 and $28,125, respectively, in directors’ fees payable that are anticipated to be paid in common stock. During the six months ended June 30, 2022 and June 30, 2021, the Company expensed $75,000 and $28,125, respectively in directors’ fees payable At June 30, 2022 and December 31, 2021, the accrued balance of stock payable to directors fees for services was $187,500 and $112,500, respectively. The Company issued no shares of common stock during the three or six months ended June 30, 2022. During the three and six months ended June 30, 2022, no warrants were exercised. Common stock warrants In February 2021, concurrent with sale of common stock, the Company issued warrants to purchase 7,650,000 shares of common stock at an exercise price of $0.85 per share. The warrants are initially exercisable six months following issuance and expire five and one-half years from the issuance date. In connection with the February 2021 sales of common stock, the Company also issued 1,606,500 warrants with an exercise price of $0.85 and 804,000 warrants with an exercise price of $0.46 as commission to the placement agent. There were no warrants exercised during the three or six months ended June 30, 2022. The Company issued no warrants to purchase common stock during the three or six months ended June 30, 2022. The following is a summary of the Company’s warrants to purchase shares of common stock activity: Number of warrants Exercise prices Balance outstanding at December 31, 2020 6,194,899 $ 0.65 Issued 10,060,500 $0.46 - $0.85 Exercised (3,765,477 ) $0.46 - $0.65 Balance outstanding at December 31, 2021 and June 30, 2022 12,489,922 $ 0.75 The composition of the Company’s warrants outstanding at June 30, 2022 is as follows: Number of warrants Exercise Price Expiration Date Remaining life (years) 143,707 $ 0.65 8/12/2022 0.12 2,285,715 0.46 7/31/2025 3.09 804,000 0.46 1/27/2026 3.58 7,650,000 0.85 8/3/2026 4.10 1,606,500 0.85 2/1/2026 3.59 12,489,922

INVESTMENTS

INVESTMENTS	6 Months Ended
	Jun. 30, 2022
INVESTMENTS
11 - INVESTMENTS	NOTE 11 – INVESTMENTS In April 2022, the Company opened an investment account composed of U.S. Treasury bonds which are measured using Level 1 fair value inputs that are based on quoted prices in active markets. For the three and six months ended June 30, 2022, the Company recognized $93,458 in the change in fair value of investments on the condensed consolidated statement of operations. As of June 30, 2022, the cost and fair value of the investment portion of the account was $13,492,655 and $13,431,774, respectively. As of June 30, 2022, the cash and cash equivalent portion of the account was $132,380, which is included in cash and cash equivalents on the condensed consolidated balance sheet.

BUSINESS SEGEMENTS

BUSINESS SEGEMENTS	6 Months Ended
	Jun. 30, 2022
BUSINESS SEGEMENTS
12.BUSINESS SEGEMENTS	NOTE 12 – BUSINESS SEGEMENTS The Company is currently organized and managed by four segments, which represent our operating units: United States antimony operations, Mexican antimony operations, precious metals recovery and United States zeolite operations. The Puerto Blanco mill and the Madero smelter at the Company’s Mexico operation bring antimony up to an intermediate or finished stage, which may be sold directly or shipped to the United States operation for finishing at the Thompson Falls, Montana plant. The Puerto Blanco mill in Mexico is the site of our crushing and flotation plant, and a cyanide leach plant which will recover precious metals after the ore goes through the crushing and flotation cycles. A precious metals recovery plant is operated in conjunction with the antimony processing plant at Thompson Falls, Montana, where a 99% precious metals mix will be produced. The zeolite operation produces zeolite near Preston, Idaho. Almost all of the sales of products from the United States antimony and zeolite operations are to customers in the United States, although the Company does have a sales operation in Canada. For the three months ended June 30, For the six months ended June 30, Capital expenditures 2022 2021 2022 2021 Antimony United States $ 51,927 $ - $ 80,277 $ - Mexico 10,724 4,872 11,565 9,744 Subtotal antimony 62,651 4,872 91,842 9,744 Precious metals 9,138 18,921 17,518 37,347 Zeolite 299,865 68,036 435,239 68,036 Total $ 371,654 $ 91,829 $ 544,599 $ 115,127 Total Assets: June 30, 2022 December 31, 2021 Antimony United States $ 24,552,558 $ 24,130,348 Mexico 7,446,054 7,771,515 Subtotal antimony 31,998,612 31,901,863 Precious metals United States 183,713 107,464 Mexico 668,929 782,854 Subtotal precious metals 852,642 890,318 Zeolite 2,904,763 2,210,546 TOTAL $ 35,756,017 $ 35,002,727 Segment operations for the three months ended June 30, 2022 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 1,644,259 $ 827,822 $ 2,472,081 $ 95,453 $ 1,020,391 $ 3,587,925 Depreciation and amortization $ 11,101 $ 143,736 $ 154,837 $ 27,674 $ 48,546 $ 231,057 Income from operations $ 120,636 $ 24,396 $ 145,032 $ 67,779 $ 154,124 $ 366,935 Other income (expense) (3,975) - (3,975) - (1,737) (5,712) NET INCOME $ 116,661 $ 24,396 $ 141,057 $ 67,779 $ 152,387 $ 361,223 Segment operations for the three months ended June 30, 2021 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 1,428,939 $ - $ 1,428,939 $ 130,195 $ 716,428 $ 2,275,562 Depreciation and amortization $ 7,893 $ 144,999 $ 152,892 $ 28,226 $ 38,826 $ 219,944 Income (loss) from operations $ 99,642 $ (575,363 ) $ (475,721 ) $ 101,969 $ 141,562 $ (232,190 ) Other income (expense) 456,725 113,422 570,147 - (816 ) 569,331 NET LOSS $ 556,367 $ (461,941 ) $ 94,426 $ 101,969 $ 140,746 $ 337,141 Segment operations for the six months ended June 30, 2022 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 4,473,189 $ 827,822 $ 5,301,011 $ 172,787 $ 1,694,433 $ 7,168,231 Depreciation and amortization $ 20,570 $ 282,193 $ 302,763 $ 55,194 $ 93,250 $ 451,207 Income (loss) from operations $ 1,512,148 $ (659,641 ) $ 852,507 $ 117,593 $ 176,415 $ 1,146,515 Other income (expense) 3,335 - 3,335 - (2,375 ) 960 NET INCOME (LOSS) $ 1,515,483 $ (659,641 ) $ 855,842 $ 117,593 $ 174,040 $ 1,147,475 Segment operations for the six months ended June 30, 2021 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 2,086,046 $ - $ 2,086,046 $ 206,428 $ 1,236,375 $ 3,528,849 Depreciation and amortization $ 15,784 $ 289,951 $ 305,735 $ 55,830 $ 80,843 $ 442,408 Income (loss) from operations $ (119,027 ) $ (813,931 ) $ (932,958 ) $ 150,598 $ 208,444 $ (573,916 ) Other income (expense) 463,360 113,422 576,782 - (1,213 ) 575,569 NET INCOME (LOSS) $ 344,333 $ (700,509 ) $ (356,176 ) $ 150,598 $ 207,231 $ 1,653

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2022
SUBSEQUENT EVENTS
13.SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS On August 8, 2022, the Company executed a Purchase Option Agreement (the ‘agreement”) with SB Wadley SA de CV (“Wadley”) whereby the Company leases, with an option to acquire, mining claims located in Mexico known as the Wadley Property. Under the agreement, the Company will pay Wadley eight monthly installments of $11,600 for the right to mine and conduct geological and resource studies on the Wadley Property. At the end of the eight months, should the Company choose to exercise the option following due diligence and assessment of geological and resource studies, the Company will pay Wadley $2,230,000 and seven annual payments of $1,160,000.

BASIS OF PRESENTATION AND SIG_2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2022
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)
Reclassifications	Certain reclassifications have been made to conform prior periods’ amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported.
COVID -19	The Company’s operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and elsewhere, causing disruptions to the Company’s business operations and management. These disruptions are most evident in the Company’s ability to retain and house employees and properly manage them while maintaining proper social distancing and with delays in obtaining materials and supplies. The effects of the continued outbreak of COVID-19 and related government responses could also include extended disruptions to supply chains and capital markets, reduced availability of contractors and a prolonged reduction in economic activity. These effects could have a variety of adverse impacts on the Company, including its ability to conduct operations. The Company has taken steps to mitigate the potential risks to suppliers and employees posed by the spread of COVID-19, including work from home policies where appropriate. The Company will continue to monitor developments affecting both its workforce and contractors, and will take additional precautions as necessary. The ultimate impact of COVID-19 depends on factors beyond management’s knowledge or control, including its duration and third-party actions to contain its spread and mitigate its public health effects. Therefore, the Company cannot estimate the potential future impact to its financial position, results of operations and cash flows, but the impacts could be material.
Investments	The Company determines the appropriate classification of investments at the time of acquisition and re-evaluates such determinations at each reporting date. Equity securities that have a readily determinable fair value are carried at fair value determined using Level 1 fair value measurement inputs with the change in fair value recognized as unrealized gain (loss) in the consolidated statement of operations each reporting period. Gains and losses on the sale of securities are recognized on a specific identification basis.
New Accounting Pronouncements	Accounting standards that have been issued or proposed by the Financial Accounting Standards Board (“FASB”) that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	6 Months Ended
	Jun. 30, 2022
Net income per share of common stock
Antidilutive securities excluded from computation of earnings per share	June 30, 2022 June 30, 2021 Warrants 12,489,922 2,471,089 Convertible preferred stock 1,692,672 1,751,005 TOTAL POSSIBLE DILUTIVE SHARES 14,182,594 4,222,094

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	6 Months Ended
	Jun. 30, 2022
REVENUE RECOGNITION
Disaggregation of revenue	For the three months ended June 30, 2022 June 30, 2021 Antimony $ 2,472,081 $ 1,428,939 Zeolite 1,020,391 716,428 Precious metals 95,453 130,195 TOTAL REVENUE BY PRODUCT $ 3,587,925 $ 2,275,562 For the six months ended June 30, 2022 June 30, 2021 Antimony $ 5,301,011 $ 2,086,046 Zeolite 1,694,433 1,236,375 Precious metals 172,787 206,428 TOTAL REVENUE BY PRODUCT $ 7,168,231 $ 3,528,849

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2022
INVENTORIES
Total inventories	June 30, 2022 December 31, 2021 Antimony Metal $ 128,591 $ 234,461 Antimony Oxide 278,134 439,086 Antimony Ore Concentrates 28,392 119,046 Total antimony 435,117 792,593 Zeolite 155,087 262,827 TOTAL INVENTORIES $ 590,204 $ 1,055,420

PROPERTIES PLANTS AND EQUIPME_2

PROPERTIES PLANTS AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2022
PROPERTIES PLANTS AND EQUIPMENT
Major components of the Company's properties	Antimony Segment Zeolite Segment Precious Metals June 30, 2022 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,759,271 $ 9,197,870 $ 4,051,016 $ 1,347,912 $ 16,356,069 Buildings 243,248 590,128 801,764 - 1,635,140 Construction in progress - 280,406 332,629 - 613,035 Land and other 2,431,387 2,656,037 16,753 - 5,104,177 4,433,906 12,724,441 5,202,162 1,347,912 23,708,421 Accumulated depreciation (2,747,396 ) (5,904,748 ) (3,318,286 ) (495,270 ) (12,465,700 ) $ 1,686,510 $ 6,819,693 $ 1,883,876 $ 852,642 $ 11,242,721 Antimony Segment Zeolite Segment Precious Metals December 31, 2021 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,684,977 $ 8,905,899 $ 3,853,056 $ 1,330,394 $ 15,774,326 Buildings 243,248 870,534 801,764 - 1,915,546 Construction in progress - 280,406 184,972 - 465,378 Land and other 2,431,387 2,640,441 16,753 - 5,088,581 $ 4,359,612 $ 12,697,280 $ 4,856,545 $ 1,330,394 $ 23,243,831 Accumulated depreciation (2,732,809 ) (5,622,555 ) (3,314,658 ) (440,076 ) (12,110,098 ) $ 1,626,803 $ 7,074,725 $ 1,541,887 $ 890,318 $ 11,133,733

ASSET RETIREMENT OBLIGATION A_2

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Tables)	6 Months Ended
	Jun. 30, 2022
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS
Changes in the asset retirement obligation	Three months ended June 30, 2022 2021 Asset retirement obligation, beginning of period $ 192,881 $ 184,219 Change in estimate of asset retirement obligation 15,596 - Accretion expense 9,680 1,732 Asset retirement obligation, end of period $ 218,157 $ 185,951 Six months ended June 30, 2022 2021 Asset retirement obligation, beginning of period $ 191,149 $ 184,219 Change in estimate of asset retirement obligation 15,596 - Accretion expense 11,412 1,732 Asset retirement obligation, end of period $ 218,157 $ 185,951

DEBT (Tables)

DEBT (Tables)	6 Months Ended
	Jun. 30, 2022
DEBT
Long-term debt	June 30, 2022 December 31, 2021 Promissory note payable to First Security Bank of Missoula, bearing interest at 2.25%, payable in 59 monthly installments of $1,409 with a final payment of $152,726 maturing November 9, 2026; collateralized by a lien on Certificate of Deposit $ 208,046 $ 215,150 Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck 148,937 - 356,983 215,150 Less current portion (91,347 ) (13,230 ) Long term portion $ 265,636 $ 201,920
Principal payments on debt	Twelve months ending June 30, Principal payment 2023 $ 91,347 2024 82,573 2025 12,925 2026 13,219 2027 156,919 $ 356,983

STOCKHOLDERS EQUITY (Tables)

STOCKHOLDERS EQUITY (Tables)	6 Months Ended
	Jun. 30, 2022
STOCKHOLDERS EQUITY (Tables)
Common stock warrant activity	Number of warrants Exercise prices Balance outstanding at December 31, 2020 6,194,899 $ 0.65 Issued 10,060,500 $0.46 - $0.85 Exercised (3,765,477 ) $0.46 - $0.65 Balance outstanding at December 31, 2021 and June 30, 2022 12,489,922 $ 0.75
Warrants outstanding	Number of warrants Exercise Price Expiration Date Remaining life (years) 143,707 $ 0.65 8/12/2022 0.12 2,285,715 0.46 7/31/2025 3.09 804,000 0.46 1/27/2026 3.58 7,650,000 0.85 8/3/2026 4.10 1,606,500 0.85 2/1/2026 3.59 12,489,922

BUSINESS SEGEMENTS (Tables)

BUSINESS SEGEMENTS (Tables)	6 Months Ended
	Jun. 30, 2022
BUSINESS SEGEMENTS
Summary of capital expenditure	For the three months ended June 30, For the six months ended June 30, Capital expenditures 2022 2021 2022 2021 Antimony United States $ 51,927 $ - $ 80,277 $ - Mexico 10,724 4,872 11,565 9,744 Subtotal antimony 62,651 4,872 91,842 9,744 Precious metals 9,138 18,921 17,518 37,347 Zeolite 299,865 68,036 435,239 68,036 Total $ 371,654 $ 91,829 $ 544,599 $ 115,127
Segment information	Total Assets: June 30, 2022 December 31, 2021 Antimony United States $ 24,552,558 $ 24,130,348 Mexico 7,446,054 7,771,515 Subtotal antimony 31,998,612 31,901,863 Precious metals United States 183,713 107,464 Mexico 668,929 782,854 Subtotal precious metals 852,642 890,318 Zeolite 2,904,763 2,210,546 TOTAL $ 35,756,017 $ 35,002,727
Summary of segement operation	Segment operations for the three months ended June 30, 2022 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 1,644,259 $ 827,822 $ 2,472,081 $ 95,453 $ 1,020,391 $ 3,587,925 Depreciation and amortization $ 11,101 $ 143,736 $ 154,837 $ 27,674 $ 48,546 $ 231,057 Income from operations $ 120,636 $ 24,396 $ 145,032 $ 67,779 $ 154,124 $ 366,935 Other income (expense) (3,975) - (3,975) - (1,737) (5,712) NET INCOME $ 116,661 $ 24,396 $ 141,057 $ 67,779 $ 152,387 $ 361,223 Segment operations for the three months ended June 30, 2021 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 1,428,939 $ - $ 1,428,939 $ 130,195 $ 716,428 $ 2,275,562 Depreciation and amortization $ 7,893 $ 144,999 $ 152,892 $ 28,226 $ 38,826 $ 219,944 Income (loss) from operations $ 99,642 $ (575,363 ) $ (475,721 ) $ 101,969 $ 141,562 $ (232,190 ) Other income (expense) 456,725 113,422 570,147 - (816 ) 569,331 NET LOSS $ 556,367 $ (461,941 ) $ 94,426 $ 101,969 $ 140,746 $ 337,141 Segment operations for the six months ended June 30, 2022 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 4,473,189 $ 827,822 $ 5,301,011 $ 172,787 $ 1,694,433 $ 7,168,231 Depreciation and amortization $ 20,570 $ 282,193 $ 302,763 $ 55,194 $ 93,250 $ 451,207 Income (loss) from operations $ 1,512,148 $ (659,641 ) $ 852,507 $ 117,593 $ 176,415 $ 1,146,515 Other income (expense) 3,335 - 3,335 - (2,375 ) 960 NET INCOME (LOSS) $ 1,515,483 $ (659,641 ) $ 855,842 $ 117,593 $ 174,040 $ 1,147,475 Segment operations for the six months ended June 30, 2021 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 2,086,046 $ - $ 2,086,046 $ 206,428 $ 1,236,375 $ 3,528,849 Depreciation and amortization $ 15,784 $ 289,951 $ 305,735 $ 55,830 $ 80,843 $ 442,408 Income (loss) from operations $ (119,027 ) $ (813,931 ) $ (932,958 ) $ 150,598 $ 208,444 $ (573,916 ) Other income (expense) 463,360 113,422 576,782 - (1,213 ) 575,569 NET INCOME (LOSS) $ 344,333 $ (700,509 ) $ (356,176 ) $ 150,598 $ 207,231 $ 1,653

NATURE OF OPERATIONS (Details N

NATURE OF OPERATIONS (Details Narrative)	6 Months Ended
	Jun. 30, 2022
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)
Name of Subsidiary 1	Bear River Zeolite Company
Place of Subsidiary 1	Idaho
Owned Percentage 1	75%
Owned Remaining Percentage 1	25%
Name of Subsidiary 2	Antimonio de Mexico S.A. de C.V
Place of Subsidiary 2	Mexico
Owned Percentage 2	100%
Name of Subsidiary 3	Mexico S.A. de C.V
Place of Subsidiary 3	United States
Owned Percentage 3	100%
Owned Percentage 4	100%
Name of Subsidiary 4	Stibnite Holding Company US Inc.
Owned Percentage 5	100%
Name of Subsidiary 5	Antimony Mining and Milling US LLC
Place of Subsidiary 5	Delaware
Owned Percentage 6	100%
Place of Subsidiary 6	Mexico
Name of Subsidiary 6	Lanxess Laurel de Mexico, S.A. de C.V

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Total possible dilution	14,182,594	4,222,094
Cumulative Preferred Stock
Total possible dilution	1,692,672	1,751,005
Warrants
Total possible dilution	12,489,922	2,471,089

REVENUE RECOGNITION (Details)

REVENUE RECOGNITION (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
TOTAL REVENUE BY PRODUCT	$ 3,587,925	$ 2,275,562	$ 7,168,231	$ 3,528,849
Precious Metals
TOTAL REVENUE BY PRODUCT	95,453	130,195	172,787	206,428
Zeolite
TOTAL REVENUE BY PRODUCT	1,020,391	716,428	1,694,433	1,236,375
Antimony
TOTAL REVENUE BY PRODUCT	$ 2,472,081	$ 1,428,939	$ 5,301,011	$ 2,086,046

REVENUE RECOGNITION (Details Na

REVENUE RECOGNITION (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
REVENUE RECOGNITION
Trademark and licensing income	$ 60,775	$ 0	$ 60,775	$ 0
Accounts receivable	$ 1,604,660		$ 1,604,660		$ 891,314

INVENTORIES (Details)

INVENTORIES (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Inventories	$ 590,204	$ 1,055,420
Antimony
Inventories	435,117	792,593
zeolite products
Inventories	155,087	262,827
Antimony Metals
Inventories	128,591	234,461
Antimony Oxides
Inventories	278,134	439,086
Antimony Ore Concentrates
Inventories	$ 28,392	$ 119,046

INVENTORIES (Details Narrative)

INVENTORIES (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
INVENTORIES
Inventories adjustmentincluded in cost of revenue	$ 136,836	$ 66,054

PROPERTIES PLANTS AND EQUIPME_3

PROPERTIES PLANTS AND EQUIPMENT (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Plant and equipment	$ 16,356,069	$ 15,774,326
Buildings	1,635,140	1,915,546
Construction in progress	613,035	465,378
Land and other	5,104,177	5,088,581
Total	23,708,421	23,243,831
Accumulated depreciation	(12,465,700)	(12,110,098)
Properties, plants and equipment, net	11,242,721	11,133,733
Antimony Segment USAC
Plant and equipment	1,759,271	1,684,977
Buildings	243,248	243,248
Construction in progress	0	0
Land and other	2,431,387	2,431,387
Total	4,433,906	4,359,612
Accumulated depreciation	(2,747,396)	(2,732,809)
Properties, plants and equipment, net	1,686,510	1,626,803
Antimony Segment USAMSA
Plant and equipment	9,197,870	8,905,899
Buildings	590,128	870,534
Construction in progress	280,406	280,406
Land and other	2,656,037	2,640,441
Total	12,724,441	12,697,280
Accumulated depreciation	(5,904,748)	(5,622,555)
Properties, plants and equipment, net	6,819,693	7,074,725
Zeolite Segment BRZ
Plant and equipment	4,051,016	3,853,056
Buildings	801,764	801,764
Construction in progress	332,629	184,972
Land and other	16,753	16,753
Total	5,202,162	4,856,545
Accumulated depreciation	(3,318,286)	(3,314,658)
Properties, plants and equipment, net	1,883,876	1,541,887
Precious Metals Segment
Plant and equipment	1,347,912	1,330,394
Buildings	0	0
Construction in progress	0	0
Land and other	0	0
Total	1,347,912	1,330,394
Accumulated depreciation	(495,270)	(440,076)
Properties, plants and equipment, net	$ 852,642	$ 890,318

PROPERTIES PLANTS AND EQUIPME_4

PROPERTIES PLANTS AND EQUIPMENT (Details Narrative) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
PROPERTIES PLANTS AND EQUIPMENT (Details)
Assets not yet placed in service	$ 613,035	$ 665,175

ASSET RETIREMENT OBLIGATION A_3

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details)
Asset retirement obligation, beginning of period	$ 192,881	$ 184,219	$ 191,149	$ 184,219
Accretion Expense	15,596	0	15,596	0
Change in estimate of asset retirement obligation	9,680	1,732	11,412	1,732
Asset retirement obligation, end of period	$ 218,157	$ 185,951	$ 218,157	$ 185,951

ASSET RETIREMENT OBLIGATION A_4

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details Narrative) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details)
Asset retirement obligation liability with reclamation obligations	$ 325,657	$ 298,649
Reclamation obligations	$ 107,500

DEBT (Details)

DEBT (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Noncurrent portion	$ 356,983	$ 215,150
Less current portion	(91,347)	(13,230)
Long term portion	265,636	201,920
First Security Bank of Missoula
Long term portion	208,046	215,150
Caterpillar Financial Services
Long term portion	$ 148,937	$ 0

DEBT (Details 1)

DEBT (Details 1)	Jun. 30, 2022 USD ($)
DEBT
2023	$ 91,347
2024	82,573
2025	12,925
2026	13,219
2027	156,919
Total	$ 356,983

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Royalty expense	$ 85,870	$ 69,437	$ 147,900	$ 131,567
Accrued liabilities	1,270		1,270		$ 0
Accrued royalties payable	$ 409,887		$ 409,887		$ 346,242
Minimum [Member]
Royalties percentage			8%
Maximum [Member]
Royalties percentage			13%

STOCKHOLDERS EQUITY (Details)

STOCKHOLDERS EQUITY (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Number of warrants, beginning	6,194,899	6,194,899
Issued	10,060,500	10,060,500
Exercised	(3,765,477)	(3,765,477)
Number of warrants, ending	12,489,922	6,194,899
Exercise prices, Balance outstanding, Beginning Balance	$ 0.65	$ 0.65
Exercise prices, Balance outstanding, Ending Balance	0.75	0.75
Minimum [Member]
Issued	0.46	0.46
Exercised	0.46	0.46
Maximum [Member]
Issued	0.85	0.85
Exercised	$ 0.65	$ 0.65

STOCKHOLDERS EQUITY (Details 1)

STOCKHOLDERS EQUITY (Details 1)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Warrant 1
Shares	143,707
Exercise Price | $ / shares	$ 0.65
Remaining life	1 month 13 days
Expiration date	8/12/2022
Warrant 2
Shares	2,285,715
Exercise Price | $ / shares	$ 0.46
Remaining life	3 years 1 month 2 days
Expiration date	7/31/
Warrant 3
Shares	804,000
Exercise Price | $ / shares	$ 0.46
Remaining life	3 years 6 months 29 days
Expiration date	1/27/
Warrant 4
Shares	7,650,000
Exercise Price | $ / shares	$ 0.85
Remaining life	4 years 1 month 6 days
Expiration date	8/3/2026
Warrant 5
Shares	1,606,500
Exercise Price | $ / shares	$ 0.85
Remaining life	3 years 7 months 2 days
Expiration date	2/1/2026
Warrants
Shares	12,489,922

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended
	Feb. 03, 2021	Feb. 18, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Common stock Issued			3,765,477		3,765,477
Directors' fees payable			$ 46,875	$ 28,125	$ 75,000	$ 28,125
Accrued balance of stock payable			$ 187,500		187,500		$ 112,500
Gross proceeds from shares sold					1,790,703
February 2021 [Member]
Gross proceeds from shares sold	$ 10,710,000	$ 14,287,000
Common stock shares sold	15,300,000	10,990,000
Total cash issuance cost					$ 1,654,820
Shares sold price per share	$ 0.70	$ 1.30
Warrant 1
Warrants sold to purchase shares of common stock					1,606,500
Warrants, exercise price			$ 0.85		$ 0.85
Warrant 2
Warrants sold to purchase shares of common stock					804,000
Warrants, exercise price			$ 0.46		$ 0.46
Common Stock Warrants
Warrants sold to purchase shares of common stock	7,650,000
Warrants, exercise price	$ 0.85

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Cash and cash equivalent	$ 8,369,750	$ 8,369,750	$ 21,420,329	$ 22,421,882	$ 722,377
Investment account
Change in fair value of investments	93,458	93,458
Fair value of investment	13,431,774	13,431,774
Cost of investment	13,492,655	13,492,655
Cash and cash equivalent	$ 132,380	$ 132,380

BUSINESS SEGEMENTS (Details)

BUSINESS SEGEMENTS (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Capital expenditures	$ 371,654	$ 91,829	$ 544,599	$ 115,127
Precious Metals
Capital expenditures	9,138	18,921	17,518	37,347
Zeolite
Capital expenditures	299,865	68,036	435,239	68,036
United States Antimony
Capital expenditures	51,927	0	80,277	0
Mexico Antimony
Capital expenditures	10,724	4,872	11,565	9,744
Subtotal Antimony
Capital expenditures	$ 62,651	$ 4,872	$ 91,842	$ 9,744

BUSINESS SEGEMENTS (Details 1)

BUSINESS SEGEMENTS (Details 1) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Total assets	$ 35,756,017	$ 35,002,727
United States Precious Metals
Total assets	183,713	107,464
Zeolite
Total assets	2,904,763	2,210,546
United States Antimony
Total assets	24,552,558	24,130,348
Mexico Antimony
Total assets	7,446,054	7,771,515
Subtotal Antimony
Total assets	31,998,612	31,901,863
Mexico Precious Metals [Member]
Total assets	668,929	782,854
Subtotal Precious Metals [Member]
Total assets	$ 852,642	$ 890,318

BUSINESS SEGEMENTS (Details 2)

BUSINESS SEGEMENTS (Details 2) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues	$ 3,587,925		$ 2,275,562		$ 7,168,231	$ 3,528,849
Depreciation and amortization	231,057		219,944		451,207	442,408
Income (loss) from operations	366,935		(232,190)		1,146,515	(573,916)
Total other income (expense)	(5,712)		569,331		960	575,569
NET INCOME (LOSS)	361,223	$ 786,252	337,141	$ (335,488)	1,147,475	1,653
Precious Metals
Revenues	95,453		130,195		172,787	206,428
Depreciation and amortization	27,674		28,226		55,194	55,830
Income (loss) from operations	67,779		101,969		117,593	150,598
Total other income (expense)	0		0		0	0
NET INCOME (LOSS)	67,779		101,969		117,593	150,598
Zeolite
Revenues	1,020,391		716,428		1,694,433	1,236,375
Depreciation and amortization	48,546		38,826		93,250	80,843
Income (loss) from operations	154,124		141,562		176,415	208,444
Total other income (expense)	(1,737)		(816)		(2,375)	(1,213)
NET INCOME (LOSS)	152,387		140,746		174,040	207,231
United States Antimony
Revenues	1,644,259		1,428,939		4,473,189	2,086,046
Depreciation and amortization	11,101		7,893		20,570	15,784
Income (loss) from operations	120,636		99,642		1,512,148	(119,027)
Total other income (expense)	(3,975)		456,725		(3,335)	463,360
NET INCOME (LOSS)	116,661		556,367		1,515,483	344,333
Mexico Antimony
Revenues	827,822		0		827,822	0
Depreciation and amortization	143,736		144,999		282,193	289,951
Income (loss) from operations	24,396		(575,363)		(659,641)	(813,931)
Total other income (expense)	0		113,422		0	113,422
NET INCOME (LOSS)	24,396		(461,941)		(659,641)	(700,509)
Subtotal Antimony
Revenues	2,472,081		1,428,939		5,301,011	2,086,046
Depreciation and amortization	154,837		152,892		302,763	305,735
Income (loss) from operations	145,032		(475,721)		852,507	(932,958)
Total other income (expense)	(3,975)		570,147		(3,335)	576,782
NET INCOME (LOSS)	$ 141,057		$ 94,426		$ 855,842	$ (356,176)

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Aug,8,2022 - SubsequentEvent	Aug. 08, 2022 USD ($)
Eight monthly installments	$ 11,600
Payment to Wadley	2,230,000
Seven annual payments	$ 1,160,000